Skip to main content
Watch Insiders
ROIV filings

Corporate insider profile

Eric Venker Filing Activity

Latest reported as President & Immunovant CEO of Roivant Sciences Ltd. (ROIV).

Purchase filings
0
Reported companies
1
Net open-market value
-$18,603,260.00
Latest transaction
Jun 24, 2026

Affiliated corporations

Reported company relationships

ROIVLatest reported

Roivant Sciences Ltd.

President & Immunovant CEO

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 24, 2026Roivant Sciences Ltd. (ROIV)President & Immunovant CEOSale200,000$33.16$6,631,260
May 22, 2026Roivant Sciences Ltd. (ROIV)President & Immunovant CEOSale200,000$30.27$6,054,000
Apr 20, 2026Roivant Sciences Ltd. (ROIV)President & Immunovant CEOSale200,000$29.59$5,918,000